![Breakthroughs that change patients’ lives]({"type":"image" , "src" : "/sda/112393/JournalAd-TACD-Pfizer-Leaderboard.jpg"})
Supplemental material
Acta Cardiologica
Volume 76, 2021 - Issue 4
Original Scientific Papers
Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and The Netherlands: insights from the ETNA-AF-Europe study
Tim A. C. de Vriesa Department of Cardiology, Rijnstate Hospital, Arnhem, The Netherlands;b Department of Cardiology, Amsterdam Medical Centres/University of Amsterdam, Amsterdam, The NetherlandsCorrespondence[email protected]
https://orcid.org/0000-0003-1392-8193View further author information
https://orcid.org/0000-0003-1392-8193View further author information, Martin E. W. Hemelsa Department of Cardiology, Rijnstate Hospital, Arnhem, The Netherlands;c Department of Cardiology, Radboud University Medical Centre, Nijmegen, The Netherlandshttps://orcid.org/0000-0002-2373-9858View further author information
https://orcid.org/0000-0002-2373-9858View further author information, Frank Coolsd Department of Cardiology, General Hospital Klinieken Noord-Antwerpen, Brasschaat, Belgiumhttps://orcid.org/0000-0001-8883-5368View further author information
https://orcid.org/0000-0001-8883-5368View further author information, Harry J. G. M. Crijnse Department of Cardiology, Maastricht University Medical Centre, Maastricht, The Netherlandshttps://orcid.org/0000-0003-1073-5337View further author information
https://orcid.org/0000-0003-1073-5337View further author information, Laetitia Yperzeelef Department of Neurosurgery, University Hospital Antwerp, Antwerp, Belgiumhttps://orcid.org/0000-0002-5503-5724View further author information
https://orcid.org/0000-0002-5503-5724View further author information, , , Patrizio Lancellottii Department of Cardiology, University Hospital of Liège, Liège, Belgiumhttps://orcid.org/0000-0002-0804-8194View further author information
https://orcid.org/0000-0002-0804-8194View further author information, Georges H. Mairessej Department of Cardiology, Cliniques du Sud-Luxembourg, Arlon, Belgiumhttps://orcid.org/0000-0002-2255-4181View further author information
https://orcid.org/0000-0002-2255-4181View further author information, Anne de Veerk Department of Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlandshttps://orcid.org/0000-0002-2016-5676View further author information
https://orcid.org/0000-0002-2016-5676View further author information, , Emmanuel Catezm Department of Cardiology, Brugmann University Hospital, Brussels, Belgiumhttps://orcid.org/0000-0002-8394-9312View further author information
https://orcid.org/0000-0002-8394-9312View further author information, Michel de Pauwn Department of Cardiology, Ghent University Hospital, Ghent, Belgiumhttps://orcid.org/0000-0001-7697-3931View further author information
https://orcid.org/0000-0001-7697-3931View further author information, Thomas Vanasscheo Department of Cardiology, Leuven University Hospital, Leuven, Belgiumhttps://orcid.org/0000-0002-7404-8918View further author information
https://orcid.org/0000-0002-7404-8918View further author information, Carlo de Asmundisp Department of Cardiology, University Hospital Brussels, Brussels, Belgiumhttps://orcid.org/0000-0001-9351-0760View further author information
https://orcid.org/0000-0001-9351-0760View further author information, Paulus Kirchhofq Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK;r The Atrial Fibrillation NETwork (AFNET), Münster, Germanyhttps://orcid.org/0000-0002-1881-0197View further author information
https://orcid.org/0000-0002-1881-0197View further author information, Raffaele De Caterinas Department of Cardiology, University of Pisa, Pisa, Italyhttps://orcid.org/0000-0003-1637-574XView further author information
https://orcid.org/0000-0003-1637-574XView further author information, Joris R. de Grootb Department of Cardiology, Amsterdam Medical Centres/University of Amsterdam, Amsterdam, The Netherlandshttps://orcid.org/0000-0002-8122-7017View further author information
https://orcid.org/0000-0002-8122-7017View further author information & On behalf of the ETNA-AF-Europe principal investigators from Belgium and the Netherlands show all![Committed to improving the lives of patients with Type 2 Diabetes, Heart Failure and Chronic Kidney Disease.]({"type":"image" , "src" : "/sda/112387/JournalAd-TACD-BOEHR-MPU.jpg"})
![Bristol Myers Squibb – symposium on hypertrophic cardiomyopathy.]({"type":"image" , "src" : "/sda/112392/Skyscraper_BristolMyersSquibb.jpg"})